Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

The Rule of Three: Mapping Physician Engagement

Understanding the nuances behind why a physician makes a decision regarding an information source when making a clinical decision is key to learning the best way to deliver content that will prompt an engagement.

Read More »

Mylan says EpiPen manufacturing partner to expand device recall

Generic drugmaker Mylan NV said its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.

Read More »

British robot helping autistic children with their social skills

Kaspar the social robot has helped around 170 autistic children in a handful of schools and hospitals over the last 10 years. But with approximately 700,000 people in Britain on the autism spectrum, according to the National Autistic Society, the university wants Kaspar to help more people.

Read More »

Jaguar Animal Health and Napo Pharmaceuticals Enter Definitive Merger Agreement

Napo Pharmaceuticals Inc. – a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas – and Jaguar Animal Health Inc. – an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals and high value horses – announced today that they have entered into a definitive merger agreement by unanimous approval by the boards of directors of both companies.

Read More »

Tagrisso Receives US FDA Full Approval

The U.S. FDA granted full approval for Tagrisso (osimertinib) 80-mg once-daily tablets for treating metastatic EGFR T790M mutation-positive NSCLC.

Read More »

Former Pfizer Neuroscientist to Helm New York Biotech Vencerx

Vencerx Therapeutics announced that Robert Ring will join the company as chief executive officer and Jeffrey Stevenson will join as chairman of the board.

Read More »

Google Backs Another Biotech Startup

GV has invested in a company called SpyBiotech, which focuses on a so-called “super glue” that combines two parts of the bacteria that causes strep throat.

Read More »

Changing the Learning Curve for Auto-Injection Therapy

As biologic medications administered through prefilled syringes continue to supplement and enter new therapeutic areas, more and more patients will need to embark on a learning curve that is possibly unlike any they have experienced prior.

Read More »

Novartis’ Talent Woes Continue as Seattle Genetics Poaches a Top CAR-T Exec

Seattle Genetics announced that Karen Walker will be joining the company as vice president of Global Quality in mid-April 2017. She was formerly vice president Global Head Cell and Gene Therapies Technical Development and Manufacturing at Novartis.

Read More »

Espero Pharmaceuticals and Armetheon to Merge

Espero Pharmaceuticals – a commercial-stage cardiovascular pharma company – and Armetheon – a late-clinical stage pharma company developing innovative novel drugs addressing major unmet needs in cardiovascular diseases – plan to merge.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom